Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy. (Q53366826)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy. (English)

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

inflammatory bowel diseases

0 references

Dominique M A Bullens

3

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

8

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

Kristel Van Steen

object named as

Kristel Van Steen

5

0 references

Gert Van Assche

9

object named as

Gert Van Assche

1 reference

Europe PubMed Central

13 May 2018

7

object named as

Paul Rutgeerts

1 reference

Europe PubMed Central

13 May 2018

4

object named as

Marc Ferrante

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

author name string

Zhe Li

1

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

Séverine Vermeire

2

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

Maja Noman

6

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

publication date

1 October 2015

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

21

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

10

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

2418-2428

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

Inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Induced and natural regulatory T cells in the development of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Regulatory T cells in the control of immune pathology.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Making sense of regulatory T cell suppressive function

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

C-reactive protein as a marker for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Biological markers in inflammatory bowel disease: practical consideration for clinicians.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Regulatory T cell kinetics in the peripheral blood of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Predictors of early response to infliximab in patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Predicting the response to infliximab from trough serum levels

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000509

21 January 2018

Identifiers

10.1097/MIB.0000000000000509

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26308438

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53366826&oldid=1569437967"